United Therapeutics Corporation
UTHR
$556.82
-$5.27-0.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 274.90M | 364.30M | 338.70M | 309.50M | 322.20M |
| Total Depreciation and Amortization | 22.60M | 22.80M | 21.90M | 21.10M | 19.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 153.40M | 103.10M | 39.00M | 64.10M | 41.20M |
| Change in Net Operating Assets | 12.40M | -144.00M | 162.50M | -203.00M | 78.00M |
| Cash from Operations | 463.30M | 346.20M | 562.10M | 191.70M | 461.20M |
| Capital Expenditure | -100.80M | -172.90M | -210.50M | -62.20M | -74.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 844.50M | -54.70M | 351.40M | -237.70M | -89.80M |
| Cash from Investing | 743.70M | -227.60M | 140.90M | -299.90M | -164.70M |
| Total Debt Issued | -- | 0.00 | 0.00 | 200.00M | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -400.00M | -100.00M |
| Issuance of Common Stock | 73.90M | 99.00M | 44.50M | 18.10M | 21.50M |
| Repurchase of Common Stock | -1.56B | -600.00K | -1.00B | -5.20M | -15.30M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -11.50M | -- |
| Cash from Financing | -1.48B | 98.40M | -956.00M | -198.60M | -93.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -277.40M | 217.00M | -253.00M | -306.80M | 202.70M |